These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 37499762)

  • 21. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
    Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
    Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
    Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
    J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography.
    Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
    Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
    Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
    Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
    Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture.
    Pavone P; Russello G; Salati G; Corsini R; Salsi P; Vizzini L; Lombardini C; Spaggiari L; Besutti G; Menozzi V; Spadoni A; Facciolongo N; Piro R; Carretto E; Massari M
    Mycoses; 2023 Mar; 66(3):219-225. PubMed ID: 36380646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.
    Feys S; Vanmassenhove S; Kraisin S; Yu K; Jacobs C; Boeckx B; Cambier S; Cunha C; Debaveye Y; Gonçalves SM; Hermans G; Humblet-Baron S; Jansen S; Lagrou K; Meersseman P; Neyts J; Peetermans M; Rocha-Pereira J; Schepers R; Spalart V; Starick MR; Thevissen K; Van Brussel T; Van Buyten T; Van Mol P; Vandenbriele C; Vanderbeke L; Wauters E; Wilmer A; Van Weyenbergh J; Van De Veerdonk FL; Carvalho A; Proost P; Martinod K; Lambrechts D; Wauters J
    Lancet Microbe; 2024 Mar; 5(3):e247-e260. PubMed ID: 38280387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
    Chong WH; Saha BK; Neu KP
    Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of risk factors and outcome of patients with and without COVID-19-associated pulmonary aspergillosis from Pakistan: A case-control study.
    Nasir N; Farooqi J; Zubair SM; Ayub M; Khan S; Wiqar MH; Mahmood SF; Jabeen K
    Mycoses; 2023 Jan; 66(1):69-74. PubMed ID: 36111367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis.
    Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J
    Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients.
    Shah M; Reveles K; Moote R; Hand E; Kellogg Iii D; Attridge RL; Maselli DJ; Gutierrez GC
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad062. PubMed ID: 36879627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.
    de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV
    Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19-Associated Pulmonary Aspergillosis in Russia.
    Shadrivova O; Gusev D; Vashukova M; Lobzin D; Gusarov V; Zamyatin M; Zavrazhnov A; Mitichkin M; Borzova Y; Kozlova O; Desyatik E; Burygina E; Ignatyeva S; Oganesyan E; Vasilyeva N; Klimko N; Working Group
    J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of glucocorticoids on the development of COVID-19-associated pulmonary aspergillosis: A meta-analysis of 21 studies and 5174 patients.
    Hashim Z; Nath A; Khan A; Gupta M; Kumar A; Chatterjee R; Dhiman RK; Hoenigl M; Tripathy NK
    Mycoses; 2023 Nov; 66(11):941-952. PubMed ID: 37551043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis.
    Hoenigl M; Egger M; Price J; Krause R; Prattes J; White PL
    J Clin Microbiol; 2023 Mar; 61(3):e0185922. PubMed ID: 36809121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant.
    Wang Y; Yao Y; Zhang Q; Chen H; He Y; Hu K
    BMC Infect Dis; 2024 Jan; 24(1):117. PubMed ID: 38263011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
    Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.